title: Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?
authors: Unità Operativa Complessa di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera di Cosenza , Cosenza , Italy.
authors: Ernesto
authors: E
authors: Vigna
authors: Anna Grazia
authors: AG
authors: Recchia
authors: Maria
authors: M
authors: Cuzzola
authors: Lucio
authors: L
authors: Morabito
authors: Massimo
authors: M
authors: Gentile
authors: Fortunato
authors: F
authors: Morabito
mesh_terms: D000368:Aged; D000748:Anemia, Macrocytic / Q000150:complications / Q000235:genetics*; D001565:Benzoates / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000187:drug effects / Q000235:genetics; D000077588:Deferasirox; D041905:Erythroid Cells / Q000187:drug effects*; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D007155:Immunologic Factors; D014230:Triazoles; D013792:Thalidomide; D000077269:Lenalidomide; D000077588:Deferasirox